- Home
- EAD vs MRK Comparison
EAD vs MRK Comparison
Compare EAD & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EAD
- MRK
- Stock Information
- Founded
- EAD 2003
- MRK 2000
- Country
- EAD United States
- MRK United States
- Employees
- EAD N/A
- MRK N/A
- Industry
- EAD Finance/Investors Services
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- EAD Finance
- MRK Health Care
- Exchange
- EAD Nasdaq
- MRK Nasdaq
- Market Cap
- EAD 404.8M
- MRK 218.8B
- IPO Year
- EAD N/A
- MRK N/A
- Fundamental
- Price
- EAD $6.90
- MRK $88.04
- Analyst Decision
- EAD
- MRK Buy
- Analyst Count
- EAD 0
- MRK 15
- Target Price
- EAD N/A
- MRK $105.14
- AVG Volume (30 Days)
- EAD 178.9K
- MRK 12.1M
- Earning Date
- EAD 01-01-0001
- MRK 10-30-2025
- Dividend Yield
- EAD 8.91%
- MRK 3.70%
- EPS Growth
- EAD N/A
- MRK 20.41
- EPS
- EAD N/A
- MRK 6.49
- Revenue
- EAD N/A
- MRK $63,616,000,000.00
- Revenue This Year
- EAD N/A
- MRK $1.76
- Revenue Next Year
- EAD N/A
- MRK $5.11
- P/E Ratio
- EAD N/A
- MRK $13.49
- Revenue Growth
- EAD N/A
- MRK 1.82
- 52 Week Low
- EAD $5.69
- MRK $73.31
- 52 Week High
- EAD $6.81
- MRK $106.62
- Technical
- Relative Strength Index (RSI)
- EAD 46.22
- MRK 60.20
- Support Level
- EAD $6.74
- MRK $86.91
- Resistance Level
- EAD $6.91
- MRK $88.79
- Average True Range (ATR)
- EAD 0.06
- MRK 1.45
- MACD
- EAD 0.01
- MRK 0.14
- Stochastic Oscillator
- EAD 50.00
- MRK 86.67
About EAD Allspring Income Opportunities Fund
Allspring Income Opportunities Fund is a diversified closed-end management investment company. Its products and services are mutual funds, closed-end funds, managed accounts services, and variable trust funds. The fund's objective is a high level of current income and capital appreciation. Its portfolio of investments is Commercial services, healthcare services, Food, Pharmaceuticals, Energy, Oil & gas, Pipelines, Diversified financial services, and Others.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).